Nisa Investment Advisors
CALA

Nisa Investment Advisors’s Calithera Biosciences, Inc CALA Stock Holding History

Nisa Investment Advisors’s Portfolio CALA Stock Details CALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-95
Closed -$4 – 2364
2021
Q3 		$4 Hold
95
– – ﹤0.01% 2279
2021
Q2 		$4 Hold
95
– – ﹤0.01% 2290
2021
Q1 		$5 Hold
95
– – ﹤0.01% 2261
2020
Q4 		$9K Buy
95
+40
+73% +$3.51K ﹤0.01% 2230
2020
Q3 		$4K Hold
55
– – ﹤0.01% 2218
2020
Q2 		$6K Hold
55
– – ﹤0.01% 2002
2020
Q1 		$5K Hold
55
– – ﹤0.01% 1963
2019
Q4 		$6K Hold
55
– – ﹤0.01% 1921
2019
Q3 		$3K Buy
55
+34
+162% +$2.72K ﹤0.01% 1968
2019
Q2 		$2K Hold
21
– – ﹤0.01% 1991
2019
Q1 		$3K Hold
21
– – ﹤0.01% 1978
2018
Q4 		$2K Hold
21
– – ﹤0.01% 1923
2018
Q3 		$2K Buy
+21
New +$2K ﹤0.01% 1958

Other funds holding CALA

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Nisa Investment Advisors's CALA Position: Q4 2021 in Review

Nisa Investment Advisors sold out of Calithera Biosciences, Inc (CALA) in Q4 2021, closing a stake of 95 shares — an estimated $4 sold.

Nisa Investment Advisors first reported a position in CALA in Q3 2018 and held it in 13 quarters. The position peaked at $9K in Q4 2020. 55 funds tracked by Wall St. Rank hold CALA as of Q4 2021.

  • Nisa Investment Advisors reported no remaining Calithera Biosciences, Inc position as of Q4 2021 after selling out during the quarter.
  • Nisa Investment Advisors sold 95 Calithera Biosciences, Inc shares in Q4 2021, an estimated $4.
  • Nisa Investment Advisors first reported a position in Calithera Biosciences, Inc in Q3 2018 and held it in 13 quarters.
  • Nisa Investment Advisors's Calithera Biosciences, Inc position peaked at $9K in Q4 2020.
  • 55 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q4 2021.

Based on Nisa Investment Advisors's 13F filing for Q4 2021, filed 3 Feb 2022.